315 related articles for article (PubMed ID: 15683253)
1. Site-specific nitration and oxidative dityrosine bridging of the tau protein by peroxynitrite: implications for Alzheimer's disease.
Reynolds MR; Berry RW; Binder LI
Biochemistry; 2005 Feb; 44(5):1690-700. PubMed ID: 15683253
[TBL] [Abstract][Full Text] [Related]
2. Peroxynitrite-mediated tau modifications stabilize preformed filaments and destabilize microtubules through distinct mechanisms.
Reynolds MR; Lukas TJ; Berry RW; Binder LI
Biochemistry; 2006 Apr; 45(13):4314-26. PubMed ID: 16566606
[TBL] [Abstract][Full Text] [Related]
3. Site-specific nitration differentially influences tau assembly in vitro.
Reynolds MR; Berry RW; Binder LI
Biochemistry; 2005 Oct; 44(42):13997-4009. PubMed ID: 16229489
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine nitration within the proline-rich region of Tau in Alzheimer's disease.
Reyes JF; Fu Y; Vana L; Kanaan NM; Binder LI
Am J Pathol; 2011 May; 178(5):2275-85. PubMed ID: 21514440
[TBL] [Abstract][Full Text] [Related]
5. A possible link between astrocyte activation and tau nitration in Alzheimer's disease.
Reyes JF; Reynolds MR; Horowitz PM; Fu Y; Guillozet-Bongaarts AL; Berry R; Binder LI
Neurobiol Dis; 2008 Aug; 31(2):198-208. PubMed ID: 18562203
[TBL] [Abstract][Full Text] [Related]
6. Nitration and oligomerization of tau induced by peroxynitrite inhibit its microtubule-binding activity.
Zhang YJ; Xu YF; Chen XQ; Wang XC; Wang JZ
FEBS Lett; 2005 Apr; 579(11):2421-7. PubMed ID: 15848182
[TBL] [Abstract][Full Text] [Related]
7. Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies.
Reynolds MR; Reyes JF; Fu Y; Bigio EH; Guillozet-Bongaarts AL; Berry RW; Binder LI
J Neurosci; 2006 Oct; 26(42):10636-45. PubMed ID: 17050703
[TBL] [Abstract][Full Text] [Related]
8. Peroxynitrite-induced nitrative and oxidative modifications alter tau filament formation.
Vana L; Kanaan NM; Hakala K; Weintraub ST; Binder LI
Biochemistry; 2011 Feb; 50(7):1203-12. PubMed ID: 21210655
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase.
Derkinderen P; Scales TM; Hanger DP; Leung KY; Byers HL; Ward MA; Lenz C; Price C; Bird IN; Perera T; Kellie S; Williamson R; Noble W; Van Etten RA; Leroy K; Brion JP; Reynolds CH; Anderton BH
J Neurosci; 2005 Jul; 25(28):6584-93. PubMed ID: 16014719
[TBL] [Abstract][Full Text] [Related]
10. Nitration in neurodegeneration: deciphering the "Hows" "nYs".
Reynolds MR; Berry RW; Binder LI
Biochemistry; 2007 Jun; 46(25):7325-36. PubMed ID: 17542619
[TBL] [Abstract][Full Text] [Related]
11. A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain.
Ercan-Herbst E; Ehrig J; Schöndorf DC; Behrendt A; Klaus B; Gomez Ramos B; Prat Oriol N; Weber C; Ehrnhoefer DE
Acta Neuropathol Commun; 2019 Dec; 7(1):192. PubMed ID: 31796124
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of peroxisomal hydroxypyruvate reductase (HPR1) by tyrosine nitration.
Corpas FJ; Leterrier M; Begara-Morales JC; Valderrama R; Chaki M; López-Jaramillo J; Luque F; Palma JM; Padilla MN; Sánchez-Calvo B; Mata-Pérez C; Barroso JB
Biochim Biophys Acta; 2013 Nov; 1830(11):4981-9. PubMed ID: 23860243
[TBL] [Abstract][Full Text] [Related]
13. Dityrosine Cross-links are Present in Alzheimer's Disease-derived Tau Oligomers and Paired Helical Filaments (PHF) which Promotes the Stability of the PHF-core Tau (297-391) In Vitro.
Maina MB; Al-Hilaly YK; Oakley S; Burra G; Khanom T; Biasetti L; Mengham K; Marshall K; Harrington CR; Wischik CM; Serpell LC
J Mol Biol; 2022 Oct; 434(19):167785. PubMed ID: 35961386
[TBL] [Abstract][Full Text] [Related]
14. Multiple oxidative post-translational modifications of human glutamine synthetase mediate peroxynitrite-dependent enzyme inactivation and aggregation.
Campolo N; Mastrogiovanni M; Mariotti M; Issoglio FM; Estrin D; Hägglund P; Grune T; Davies MJ; Bartesaghi S; Radi R
J Biol Chem; 2023 Mar; 299(3):102941. PubMed ID: 36702251
[TBL] [Abstract][Full Text] [Related]
15. Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta.
Atwood CS; Perry G; Zeng H; Kato Y; Jones WD; Ling KQ; Huang X; Moir RD; Wang D; Sayre LM; Smith MA; Chen SG; Bush AI
Biochemistry; 2004 Jan; 43(2):560-8. PubMed ID: 14717612
[TBL] [Abstract][Full Text] [Related]
16. Targeting post-translational modifications on tau as a therapeutic strategy for Alzheimer's disease.
Marcus JN; Schachter J
J Neurogenet; 2011 Dec; 25(4):127-33. PubMed ID: 22091726
[TBL] [Abstract][Full Text] [Related]
17. Selective tau tyrosine nitration in non-AD tauopathies.
Reyes JF; Geula C; Vana L; Binder LI
Acta Neuropathol; 2012 Jan; 123(1):119-32. PubMed ID: 22057784
[TBL] [Abstract][Full Text] [Related]
18. Peroxynitrite modulates acidic fibroblast growth factor (FGF-1) activity.
Bagnasco P; MacMillan-Crow LA; Greendorfer JS; Young CJ; Andrews L; Thompson JA
Arch Biochem Biophys; 2003 Nov; 419(2):178-89. PubMed ID: 14592461
[TBL] [Abstract][Full Text] [Related]
19. Peroxynitrite and hemoglobin-mediated nitrative/oxidative modification of human plasma protein: effects of some flavonoids.
Wang N; Li D; Lu NH; Yi L; Huang XW; Gao ZH
J Asian Nat Prod Res; 2010 Apr; 12(4):257-64. PubMed ID: 20419535
[TBL] [Abstract][Full Text] [Related]
20. Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments.
Barghorn S; Mandelkow E
Biochemistry; 2002 Dec; 41(50):14885-96. PubMed ID: 12475237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
